The epidemiology and burden of liver disease in Australia with an emphasis on non-alcoholic fatty liver disease.

澳大利亚肝病的流行病学和负担，重点是非酒精性脂肪肝。

• 批准号: nhmrc : 1055948
• 负责人: Dr Suzanne Mahady
• 金额: $ 10.08万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/epidemiology-burden-liver-liver-disease/112514
• 关键词: epidemiology; burden; liver; disease; Australia

Non alcoholic fatty liver disease is now the commonest cause of abnormal liver function in Australia due to its close association with the obesity epidemic. It is likely to become the leading cause of liver failure and liver cancer over the next few decades. Despite this, the prevalence in Australian populations is unknown. The aim of this project is to assess how common this disorder is, the burden it places on the healthcare system and the effectiveness of treatment for liver cancer caused by advanced non alcoholic fatty liver disease.

非酒精性脂肪肝疾病现在是澳大利亚肝功能异常的最常见原因，因为它与肥胖流行病密切相关。它可能成为未来几十年肝衰竭和肝癌的主要原因。尽管如此，澳大利亚人群的患病率尚不清楚。该项目的目的是评估这种疾病的常见程度，它对医疗保健系统的负担以及治疗晚期非酒精性脂肪肝引起的肝癌的有效性。